See more : Anchorstone Holdings Limited (1592.HK) Income Statement Analysis – Financial Results
Complete financial analysis of MedAdvisor Limited (MDR.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedAdvisor Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Tesla, Inc. (TL0.DE) Income Statement Analysis – Financial Results
- Runway Growth Finance Corp. – 7 (RWAYL) Income Statement Analysis – Financial Results
- The Greenbrier Companies, Inc. (GBX) Income Statement Analysis – Financial Results
- Shanghai International Port (Group) Co., Ltd. (600018.SS) Income Statement Analysis – Financial Results
- Tourism Finance Corporation of India Limited (TFCILTD.NS) Income Statement Analysis – Financial Results
MedAdvisor Limited (MDR.AX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.mymedadvisor.com
About MedAdvisor Limited
MedAdvisor Limited, together with its subsidiaries, develops and delivers software in Australia, the United States, the United Kingdom, and Asia. The company provides MedAdvisor, a medication and adherence platform that focuses on improving health outcomes by connecting health professionals with their patients using technology and enhancing medication adherence through health programs; THRiV, an intelligent digital adherence solution; and GuildCare, a cloud-based platform that offers healthcare solutions and medicines information for consumers, health professionals, and other partners. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 122.11M | 97.96M | 67.75M | 38.77M | 9.60M | 8.24M | 6.60M | 4.24M | 1.43M | 1.65M | 1.07M | 857.14K | 0.00 | 0.00 |
| Cost of Revenue | 98.47M | 85.38M | 69.59M | 44.83M | 13.23M | 10.03M | 6.06M | 3.84M | 2.92M | 1.79M | 1.43M | 1.03M | 0.00 | 0.00 |
| Gross Profit | 23.63M | 12.59M | -1.84M | -6.06M | -3.63M | -1.78M | 549.01K | 402.53K | -1.49M | -144.30K | -362.84K | -168.40K | 0.00 | 0.00 |
| Gross Profit Ratio | 19.35% | 12.85% | -2.72% | -15.62% | -37.82% | -21.65% | 8.31% | 9.49% | -104.80% | -8.77% | -34.06% | -19.65% | 0.00% | 0.00% |
| Research & Development | 0.00 | 7.51M | 6.15M | 4.81M | 2.50M | 7.38M | 3.66M | 1.81M | 231.06K | 150.15K | 820.64K | 1.03M | 0.00 | 0.00 |
| General & Administrative | 46.42M | 41.47M | 32.24M | 282.07K | 217.89K | 187.25K | 181.13K | 193.83K | 148.06K | 120.65K | 1.32M | 1.85M | 319.63K | 35.01K |
| Selling & Marketing | 2.68M | 3.26M | 2.66M | 2.24M | 5.66M | 5.20M | 4.13M | 2.89M | 863.60K | 397.00K | 385.81K | 77.30K | 0.00 | 0.00 |
| SG&A | 49.10M | 12.80M | 8.20M | 7.45M | 5.00M | 5.39M | 4.31M | 3.08M | 1.01M | 120.65K | 1.32M | 1.85M | 319.63K | 35.01K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 1.47M | 1.36M | 816.60K | 634.27K | 562.84K | 281.21K | 546.91K | 4.65K | -192.29K | 793.49K | 59.50K |
| Operating Expenses | 20.93M | 20.30M | 14.35M | 12.26M | 7.50M | 6.45M | 5.16M | 3.93M | 1.63M | 667.56K | 11.16M | 3.65M | 1.11M | 94.51K |
| Cost & Expenses | 119.41M | 105.68M | 83.94M | 57.09M | 20.74M | 16.48M | 11.21M | 7.77M | 4.55M | 667.56K | 11.16M | 3.65M | 1.11M | 94.51K |
| Interest Income | 156.13K | 51.51K | 2.33K | 38.57K | 109.21K | 134.50K | 155.22K | 95.22K | 50.62K | 3.44K | 29.97K | 93.02K | 119.71K | 24.28K |
| Interest Expense | 1.93M | 2.13M | 1.54M | 422.09K | 115.10K | 16.31K | 11.96K | 73.06K | 8.83K | 2.85K | 16.61K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.20M | 5.35M | 4.90M | 3.21M | 512.22K | 259.31K | 196.99K | 140.33K | 33.82K | 957.00 | 4.24K | 1.43K | 155.00 | 0.00 |
| EBITDA | 7.05M | -3.03M | -11.29M | -14.93M | -10.34M | -7.83M | -4.24M | -3.40M | -2.88M | -666.01K | -11.14M | -3.75M | -993.26K | -94.51K |
| EBITDA Ratio | 5.77% | -2.41% | -16.66% | -38.95% | -110.60% | -98.39% | -69.20% | -80.25% | -202.12% | -40.30% | -1,044.18% | -425.40% | 0.00% | 0.00% |
| Operating Income | 2.70M | -7.72M | -16.19M | -18.31M | -11.13M | -8.22M | -4.60M | -3.45M | -2.92M | -667.56K | -11.16M | -3.65M | -1.11M | -94.51K |
| Operating Income Ratio | 2.21% | -7.88% | -23.89% | -47.23% | -115.93% | -99.73% | -69.61% | -81.39% | -204.49% | -40.56% | -1,047.83% | -425.57% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.77M | -2.80M | -1.54M | 1.09M | 164.79K | 934.79K | 777.53K | 586.28K | -155.49K | 27.54K | -9.57M | 93.02K | 119.71K | 24.28K |
| Income Before Tax | 923.58K | -10.52M | -17.73M | -18.56M | -10.97M | -8.10M | -4.45M | -3.43M | -3.07M | -666.97K | -11.14M | -3.75M | -993.41K | -70.23K |
| Income Before Tax Ratio | 0.76% | -10.73% | -26.17% | -47.87% | -114.22% | -98.29% | -67.44% | -80.84% | -215.39% | -40.53% | -1,046.14% | -437.15% | 0.00% | 0.00% |
| Income Tax Expense | 131.45K | 789.88K | -239.83K | -4.19M | -1.19M | -749.55K | -634.27K | -522.03K | -281.21K | 3.44K | 21.26K | -93.02K | 0.00 | 0.00 |
| Net Income | 792.13K | -11.31M | -17.35M | -13.95M | -9.58M | -8.10M | -4.45M | -3.43M | -3.07M | -666.97K | -11.14M | -3.75M | -993.41K | -70.23K |
| Net Income Ratio | 0.65% | -11.54% | -25.60% | -35.98% | -99.82% | -98.29% | -67.44% | -80.84% | -215.39% | -40.53% | -1,046.14% | -437.15% | 0.00% | 0.00% |
| EPS | 0.00 | -0.02 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.04 | -0.06 | -1.05 | -0.47 | -0.27 | -0.07 |
| EPS Diluted | 0.00 | -0.02 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.04 | -0.06 | -1.05 | -0.47 | -0.27 | -0.07 |
| Weighted Avg Shares Out | 548.12M | 544.96M | 378.12M | 316.51M | 235.29M | 194.32M | 174.94M | 122.50M | 79.77M | 11.99M | 10.64M | 7.94M | 3.69M | 1.07M |
| Weighted Avg Shares Out (Dil) | 597.12M | 544.96M | 378.12M | 316.51M | 235.29M | 194.32M | 174.94M | 123.08M | 79.99M | 11.99M | 10.64M | 7.94M | 3.69M | 1.07M |
Source: https://incomestatements.info
Category: Stock Reports